IMFINZI 50 mg/mL concentrate for solution for infusion., TREMELIMUMAB
IMMUWIN
Phase 2 small_molecule active
Quick answer
IMFINZI 50 mg/mL concentrate for solution for infusion., TREMELIMUMAB for Intermediate stage hepatocellular carcinoma (HCC) is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Intermediate stage hepatocellular carcinoma (HCC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active